← Back
Data updated: Mar 10, 2026
PRAXGEN
Infectious DiseaseOncology
PRAXGEN is a generic drug manufacturer focused on Infectious Disease, Oncology. Key products include LEVOLEUCOVORIN CALCIUM.
2019
Since
4
Drugs
-
Trials
105
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
DOXYCYCLINE HYCLATE 2025-11-19
DOXYCYCLINE HYCLATE 2025-11-06
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Infectious Disease 50%
1 drugs
Oncology 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (2)
Company Info
- First Approval
- 2019-06-27
- Latest
- 2025-03-31
- Applications
- 4